|
C1GALT1C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.824200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.180200E-03 |
| Normal-vs-Stage2 |
7.471200E-01 |
| Normal-vs-Stage3 |
3.762800E-01 |
| Normal-vs-Stage4 |
2.435700E-03 |
| Stage1-vs-Stage2 |
1.943030E-01 |
| Stage1-vs-Stage3 |
1.469350E-01 |
| Stage1-vs-Stage4 |
2.197600E-01 |
| Stage2-vs-Stage3 |
4.652400E-01 |
| Stage2-vs-Stage4 |
1.035570E-01 |
| Stage3-vs-Stage4 |
4.419800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.149600E-02 |
| Normal-vs-AfricanAmerican |
4.095200E-01 |
| Normal-vs-Asian |
6.038400E-01 |
| Caucasian-vs-AfricanAmerican |
4.258400E-01 |
| Caucasian-vs-Asian |
6.739000E-01 |
| AfricanAmerican-vs-Asian |
9.980200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.544040E-03 |
| Normal-vs-Female |
4.210600E-01 |
| Male-vs-Female |
7.5439000000066E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.781200E-03 |
| Normal-vs-Extreme_Weight |
1.228190E-02 |
| Normal-vs-Obese |
4.013800E-01 |
| Normal-vs-Extreme_Obese |
1.043850E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.320400E-01 |
| Normal_Weight-vs-Obese |
1.038800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.625400E-01 |
| Extreme_Weight-vs-Obese |
1.376830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.780400E-01 |
| Obese-vs-Extreme_Obese |
4.197800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.704800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.981600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.051640E-02 |
| Normal-vs-Age(81-100Yrs) |
1.188640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.388800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.076600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.446370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.644000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.977000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.453400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.303800E-02 |
| Normal-VS-Type2 PRCC |
1.130020E-02 |
| Normal-VS-KIRP CIMP |
2.853600E-01 |
| Normal-VS-Unclassified PRCC |
3.953800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.638800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.278020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.671800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.057170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.207360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.984400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.944300E-02 |
| Normal-vs-N1 |
6.060200E-01 |
| Normal-vs-N2 |
5.204400E-01 |
| N0-vs-N1 |
2.738000E-01 |
| N0-vs-N2 |
2.636000E-01 |
| N1-vs-N2 |
4.166600E-01 |
|
|
